Selected article for: "drug acquisition and Explicit time interval"
Author: Patricia Rios; Amruta Radhakrishnan; Sonia M. Thomas; Nazia Darvesh; Sharon E. Straus; Andrea C. Tricco
Title: Guidelines for preventing respiratory illness in older adults aged 60 years and above living in long-term care: A rapid review of clinical practice guidelines
  • Document date: 2020_3_26
    • ID: kwncu3ji_259
    Snippet: ☐Information/description of the cost information that emerged from the inquiry (e.g., specific drug acquisition costs per treatment course) ☐How the information gathered was used to inform the guideline development process and/or formation of the recommendations 21. MONITORING/ AUDITING CRITERIA Provide monitoring and/or auditing criteria to measure the application of guideline recommendations. ☒A statement that the guideline will be update.....
    Document: ☐Information/description of the cost information that emerged from the inquiry (e.g., specific drug acquisition costs per treatment course) ☐How the information gathered was used to inform the guideline development process and/or formation of the recommendations 21. MONITORING/ AUDITING CRITERIA Provide monitoring and/or auditing criteria to measure the application of guideline recommendations. ☒A statement that the guideline will be updated ☒Explicit time interval or explicit criteria to guide decisions about when an update will occur ☐Methodology for the updating procedure ☒Additional materials to support the implementation of the guideline in practice.

    Search related documents:
    Co phrase search for related documents
    • auditing CRITERIA and drug acquisition: 1, 2, 3, 4, 5, 6, 7, 8
    • auditing CRITERIA and drug acquisition cost: 1, 2, 3, 4, 5, 6, 7, 8
    • auditing CRITERIA and explicit time interval: 1
    • auditing CRITERIA and guideline development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • auditing CRITERIA and guideline development process: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • auditing CRITERIA and guideline implementation: 1, 2, 3, 4, 5, 6, 7
    • auditing CRITERIA and guideline implementation support: 1
    • cost information and drug acquisition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cost information and drug acquisition cost: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cost information and explicit time interval: 1, 2
    • cost information and guideline development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • cost information and guideline development process: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cost information and guideline implementation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cost information and guideline implementation support: 1, 2, 3, 4, 5, 6, 7, 8
    • cost information and information gather: 1, 2, 3, 4
    • drug acquisition and explicit time interval: 1, 2
    • drug acquisition and guideline development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • drug acquisition and guideline development process: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • drug acquisition and guideline implementation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12